Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

3102 ARTÍCULOS , VIENDO DEL 1216 AL 1230

[Intraduodenal infusion of levodopa]

Valldeoriola F, Cámara A.

Rev Neurol. 2010 Jul 1;51(1):41-8.

Increased reaction time predicts visual learning deficits in Parkinson's disease

Marinelli L, Perfetti B, Moisello C, Di Rocco A, Eidelberg D, Abbruzzese G, Ghilardi MF.

Mov Disord. 2010 Jul 30;25(10):1498-501. doi: 10.1002/mds.23156.

A double-blind, placebo-controlled study to assess the mitochondria-targeted antioxidant MitoQ as a disease-modifying therapy in Parkinson's disease

Snow BJ, Rolfe FL, Lockhart MM, Frampton CM, O'Sullivan JD, Fung V, Smith RA, Murphy MP, Taylor KM; Protect Study Group.

Mov Disord. 2010 Aug 15;25(11):1670-4. doi: 10.1002/mds.23148.

[What can we think about whole-body-vibration in elderly people?]

Raschilas F, Blain H.

Presse Med. 2010 Oct;39(10):1032-7. doi: 10.1016/j.lpm.2010.04.010. Epub 2010 May 31.

A systems biology viewpoint on autophagy in health and disease

Huett A, Goel G, Xavier RJ.

Curr Opin Gastroenterol. 2010 Jul;26(4):302-9. doi: 10.1097/MOG.0b013e32833ae2ed.

Neuroinflammation is a key player in Parkinson's disease and a prime target for therapy

Qian L, Flood PM, Hong JS.

J Neural Transm (Vienna). 2010 Aug;117(8):971-9. doi: 10.1007/s00702-010-0428-1. Epub 2010 Jun 23.

Entacapone

Müller T.

Expert Opin Drug Metab Toxicol. 2010 Aug;6(8):983-93. doi: 10.1517/17425255.2010.502167.

Microglia in the healthy and degenerating retina: insights from novel mouse models

Karlstetter M, Ebert S, Langmann T.

Immunobiology. 2010 Sep-Oct;215(9-10):685-91. doi: 10.1016/j.imbio.2010.05.010. Epub 2010 Jun 4.

Mitochondrial dysfunction: a potential link between neuroinflammation and neurodegeneration?

Witte ME, Geurts JJ, de Vries HE, van der Valk P, van Horssen J.

Mitochondrion. 2010 Aug;10(5):411-8. doi: 10.1016/j.mito.2010.05.014. Epub 2010 Jun 1.

The transcription factor orthodenticle homeobox 2 influences axonal projections and vulnerability of midbrain dopaminergic neurons

Chung CY, Licznerski P, Alavian KN, Simeone A, Lin Z, Martin E, Vance J, Isacson O.

Brain. 2010 Jul;133(Pt 7):2022-31. doi: 10.1093/brain/awq142. Epub 2010 Jun 23.

Predicting falls in Parkinson disease: a step in the right direction

Thevathasan W, Aziz T.

Neurology. 2010 Jul 13;75(2):107-8. doi: 10.1212/WNL.0b013e3181e7b6b5. Epub 2010 Jun 23.

Role of the glucose-dependent insulinotropic polypeptide and its receptor in the central nervous system: therapeutic potential in neurological diseases

Figueiredo CP, Pamplona FA, Mazzuco TL, Aguiar AS Jr, Walz R, Prediger RD.

Behav Pharmacol. 2010 Sep;21(5-6):394-408. doi: 10.1097/FBP.0b013e32833c8544.

Cognitive impairment in patients with multiple system atrophy and progressive supranuclear palsy

Brown RG, Lacomblez L, Landwehrmeyer BG, Bak T, Uttner I, Dubois B, Agid Y, Ludolph A, Bensimon G, Payan C, Leigh NP; NNIPPS Study Group.

Brain. 2010 Aug;133(Pt 8):2382-93. doi: 10.1093/brain/awq158. Epub 2010 Jun 24.

Partial agonist therapy in schizophrenia: relevance to diminished criminal responsibility

Gavaudan G, Magalon D, Cohen J, Lançon C, Léonetti G, Pélissier-Alicot AL.

J Forensic Sci. 2010 Nov;55(6):1659-62. doi: 10.1111/j.1556-4029.2010.01483.x.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias